HCA HEALTHCARE INC (HCA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for HCA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HCA | Director | 63 | ["served as President and Chief Executive Officer of Norwegian Cruise Line Holdings Ltd.","served as Chief Executive Officer of Subway","served as Chief Executive Officer of Burger King Holdings, Inc.","held various senior financial leadership roles at PepsiCo, Inc.","served on the board of multiple companies including Encompass Health Corporation and Brinker International, Inc.","experience leading large global consumer companies"] | ["Audit & Compliance","Compensation","Patient Safety & Quality of Care"] | 2026 |
Biography sourced from the proxy statement filing.
John W. Chidsey, III has served as the President and Chief Executive Officer of Norwegian Cruise Line Holdings Ltd. since February 2026. Previously, he served as the Chief Executive Officer of Subway from November 2019 to December 2024. He previously served as Chief Executive Officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier in his career, he also held various senior financial leadership roles at PepsiCo, Inc. Mr. Chidsey has served on the board of Norwegian Cruise Line Holdings Ltd. since February 2025 and previously served as a director of that company from 2013 to 2022. He has also served as a director of Encompass Health Corporation from 2007 to 2024, Brinker International, Inc. in 2019 and Burger King Holdings, Inc. from 2005 to 2010. Among other qualifications, Mr. Chidsey was selected as a director in light of his experience leading large global consumer companies with strong strategic and operational execution, as well as his experience serving as a director of several firms, including public companies. We believe this experience will continue to be beneficial in providing the Board of Directors with a patient-experience focus and business management and operational expertise.